Federal reimbursement programs such as Medicare and Medicaid, for example, have been trying to shift to a «value - based» payment model, where providers sometimes receive fixed payments to encourage them to control costs.
Not exact matches
Omada Health has accomplished a rare feat in the crowded world of digital health hopefuls: it's backed up lofty claims with actual results, helping the company score
federal government
reimbursements for its high - tech diabetes prevention
program.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or
reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations in ADAP purchases driven by
federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase
program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
I just learned that late last month, the USDA announced the
federal reimbursement rates for the 2010 - 2011 school lunch
program (for background on
federal reimbursement and how it works, see my School Lunch FAQs).
The new contract spells the end of the district's short - lived foray into the National School Lunch
Program, which provides
federal reimbursements in exchange for offering healthy free or reduced - cost meals to low - income students.
As for their salaries, the «operation of the
program» is funded through (a)
federal reimbursement, which is derived from taxpayer dollars and (b) cash payments from district parents who can afford to pay for all or a portion of their children's meals.
Because most school districts do not keep detailed records regarding the cost and revenue associated with various components of the school food
program, it is often difficult to gain a clear picture of how they use
federal reimbursements (except where USDA has conducted rigorous studies).
Several studies have found that decreased access to competitive foods leads to increased participation in the National School Lunch
Program and subsequent increases in
federal reimbursements and overall revenue.
First, Congress could ensure that
federal per - meal
reimbursements are not used to cover costs associated with foods offered outside of the
federal school meals
programs.
[31] Once school districts have earned
federal reimbursements through the National School Lunch or School Breakfast
Programs by serving reimbursable meals, they may spend the funds on any nonprofit school food
program they operate.
There is no regulatory requirement that
federal reimbursements for free and reduced price meals be spent only on those meals or that records differentiate between the costs and revenues of the various aspects of the school food
program.
For most Vermont schools, the per - meal
reimbursement and commodities provided by the
federal school breakfast and lunch
programs is not sufficient to cover all of these school meal
program costs.
A school breakfast
program can also increase jobs and give your school additional revenue through
federal reimbursement.
Kentucky districts participating in the national school meal
programs served more than 128 million breakfasts and lunches during the 2013 - 14 school year, resulting in more than $ 265 million in
federal reimbursements.
School meal
programs are self - sustaining, funded through
federal reimbursements and sales revenue, and independent of school district education budgets.
Alabama districts participating in national school meal
programs served more than 129 million breakfasts and lunches during the 2013 - 14 school year, resulting in more than $ 272 million in
federal reimbursements through the national school breakfast and lunch
programs.
The
federal government plays a vital role in the success of these
programs: providing
reimbursements for each meal served, ensuring equal access to free and reduced price meals for students in need and administering national nutrition standards.
Championed by the first lady, the law extends to all states the
federal reimbursement for school suppers, a
program initially limited to Illinois, 12 other states and the District of Columbia.
An afterschool meals
program can also help you bring in more
federal reimbursements.
School decision makers 1) plug in simple information, 2) explore different ways to expand school meals
programs like moving breakfast to the classroom or serving afterschool meals, and 3) come out with hard data about costs, number of students served and
federal reimbursement dollars.
Tables showing the per meal
federal reimbursement rates for the Afterschool Meal
Program and Summer Food Service Program, as well as projected annual program income based on the number of children
Program and Summer Food Service
Program, as well as projected annual program income based on the number of children
Program, as well as projected annual
program income based on the number of children
program income based on the number of children served.
Advocates can expand the Afterschool Meal
Program and obtain federal reimbursement using proven outreach strategies, including promoting the program, building relationships with afterschool and out - of - school time provider networks, connecting sites to available community resources, and working closely with the state
Program and obtain
federal reimbursement using proven outreach strategies, including promoting the
program, building relationships with afterschool and out - of - school time provider networks, connecting sites to available community resources, and working closely with the state
program, building relationships with afterschool and out - of - school time provider networks, connecting sites to available community resources, and working closely with the state agency.
The report makes some controversial proposals to a system known as the «Cadillac» of Medicaid
programs (because it covers so much), including changing the way
reimbursement rates are set, a complete state takeover of the responsibilities now borne by the counties, reform of the medical malpractice system and a push for a higher
federal contribution.
NUMC is run by a public benefit corporation, the Nassau Health Care Corporation, and would receive
federal reimbursements for treatment under the Veterans Choice
Program, Martins said.
A longer one, though, could imperil many of the services that we provide to our citizens, as we administer a wide array of
federal programs and rely on them for
reimbursement of
program costs.
The state's 57 counties (and New York City) administer hundreds of
federal and state
programs, he noted, «all on a
reimbursement basis, where the local taxpayer bears 100 percent of the cost up front.»
The only way to change the Medicaid
reimbursement rate is through Congress, and if that does not happen, an administrative waiver that brings back
federal dollars to reduce the costs of care takes on even greater importance because the island will need to find a way to stretch the dollars it does receive, and reduce the overall expense of the
program.
According to Legislator Jay Schneiderman (I - Montauk), a portion of Drinking Water Protection
Program money goes toward paying the salaries of certain county employees, positions that are also eligible for state and
federal reimbursements.
While recent
federal legislation and changes to the U.S. Medicare
program have expanded opportunities for certified registered nurse anesthetists (CRNAs) to provide care to more patients and receive
reimbursement for their services, many states still restrict their scope of practice and limit their pay.
And, in a time of increasing costs and decreasing revenues, some district leaders and food advocates worry whether 6 cents will allow schools to serve healthier fare, when the current
federal reimbursement of $ 2.72 per free meal already has many school
programs running in the red.
That is exactly what Rebecca Mozaffarian, project manager for the Harvard Prevention Research Center, set out to do in her work with YMCA afterschool
programs around the country where they were charged with finding healthier snack and drink alternatives to fit within the 76 - cent per child
federal reimbursement for afterschool
programs.
She led successful 2007 efforts to require accurate developmental screening in Head Start
programs and partnered with
federal policymakers to ensure insurance
reimbursement for such screenings.
Sen. Stein told Sen. Tillman he'd be all for local public schools sharing the
reimbursements the
federal government pays to local public schools for indirect costs they incur participating in the
federal school lunch
program — like facility fees, heating and air conditioning, staff, etc. — if Tillman would offer up a provision to require all charter schools to provide school lunch.
According to Kate Baker, the president of NEO, the
reimbursement model has been «a significant burden» for many families.25 Since NEO prioritizes based on need, 98 percent of homeschooling scholarship families in the first year of the
program had a total household income that would have qualified them for the
federal free or reduced - price lunch
program (185 percent of the
federal poverty line, or $ 43,568 for a family of four in 2012 - 13), including 77 percent who would have qualified for a «free lunch» (130 percent of the
federal poverty line, or $ 30,615 for a family of four in 2012 - 13).26
One key difference, however, is that the Barefoot - Hise proposal would order traditional school systems to share myriad funds currently not accessible to charters, including gifts, sales tax dollars and
federal grants and
reimbursements, at least one pool of which is used to offset the costs of school lunch
programs, even though many charters do not participate in such
programs.
But in its recent reauthorization of child nutrition
programs, Congress» direction is that
federal reimbursement funds should really go for meals and delivering those meals,» she said.
The
federal government plays a vital role in the success of these
programs: providing
reimbursements for each meal served, ensuring equal access to free and reduced price meals for students in need and administering national nutrition standards.
Proposed
federal cuts to Medicaid funding threaten to eliminate more than $ 140 million in
federal reimbursements to PA school districts, charter schools, vocational schools, and pre-school early intervention
programs.
The
federal government provides
reimbursement for free, reduced - price and paid lunches and breakfasts under the National School Lunch
Program.
In 2015,
federal Medicaid
reimbursements to school districts, intermediate units, charter schools, vocational - technical schools, and preschool early intervention
programs in PA totaled more than $ 104 million.
Federal reimbursements are projected to increase from $ 194.7 million in FY2013 to $ 201.1 million in FY2014 with an increased
reimbursement rate, higher contribution of donated food, and increased participation rate in the snacks and after - school
program.
Federal appropriations for
programs that charters don't provide, indirect cost
reimbursements for school lunches that charters don't offer, and grant awards specifically targeted toward traditional public schools that support innovative methods to boost student achievement could all be up for grabs by charter schools.
But with
reimbursement from the
federal E-rate
program, which helps provide connectivity to low - income districts, Lower Kuskokwim pays only about $ 2.5 million annually for the Internet services, he said.
A closed school discharge is a 100 % discharge of the
federal Direct Loans, Federal Family Education Loan (FFEL) Program loans, or Federal Perkins Loans you took out to attend the closed school and a reimbursement of amounts you have already paid to the gove
federal Direct Loans,
Federal Family Education Loan (FFEL) Program loans, or Federal Perkins Loans you took out to attend the closed school and a reimbursement of amounts you have already paid to the gove
Federal Family Education Loan (FFEL)
Program loans, or
Federal Perkins Loans you took out to attend the closed school and a reimbursement of amounts you have already paid to the gove
Federal Perkins Loans you took out to attend the closed school and a
reimbursement of amounts you have already paid to the government.
He has developed corporate compliance
programs designed to identify Medicare and Medicaid
reimbursement and certification issues, licensing and
federal regulatory compliance matters, fraud and abuse issues, as well other regulatory compliance matters.
• Planned, coordinated and implemented food service
programs in compliance with USDA standards and
Federal Meal
Reimbursement program requirements • Handled procurement and maintenance of food and supply inventories for kitchen and commissary.
Coordinated Division Travel and Expense
Reimbursement Program (Communicate program policies to Division employees and work with Finance to ensure compliance with federal and state pol
Program (Communicate
program policies to Division employees and work with Finance to ensure compliance with federal and state pol
program policies to Division employees and work with Finance to ensure compliance with
federal and state policies).
The majority of
federal funding that Planned Parenthood health centers receive are through Medicaid
reimbursements or grants through the
federal family planning
program, Title X.
The majority of
federal funds come through Planned Parenthood health centers via
reimbursements for the medical services that they provide to patients who either have Medicaid coverage or qualify for other publicly funded health care
programs (like Title X).
Reimbursement to Planned Parenthood from
federal health coverage
programs provides preventive health care to millions of women, and it reduces the burden of unplanned pregnancy in our country.